drugset / Trial / NCT05209867

Single-cell CBD Biomarkers of Inflammation Reduction in People Living With HIV

NCT05209867

NaSingle-groupOpen-labelTreatment

Summary

People living with HIV (PLWH) are affected by comorbidities appearing to be strongly related to chronic inflammation, a condition characterizing PLWH. The investigators propose to study the effects of CBD on inflammation in PLWH, and establish the molecular role of different immune cells in this process. The investigators plan to use single cell RNA-sequencing (scRNAseq) to isolate CBD-specific cellular phenotypes from five persons with HIV who will provide blood samples before and after taking CBD.

Timeline

Start
2022-05-01
Primary completion
2022-12-12
Completion
2022-12-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabidiol Other / unclassified 63 mg Other